WELCOME, DARWIN ANTHONY LEÓN FIGUEROA MORE

Global Health Training Centre What are you looking for? SEARCH

Home eLearning Courses Professional Development Webinars and Workshops Community Resources About This Site FAQ

eLearning Courses
The name that will appear on your certificate is Darwin Anthony León Figueroa. DOWNLOAD MATERIALS:

Essential Element 3: Quiz This Course (PDF)

RESULTS RETAKE

CONTENT NAVIGATION

Essential Element 3: Quiz 1. Essential Element 3: Quiz

Please do not start this quiz unless you have taken all the quizzes for the previous modules -- you
will not be able to get your certificate unless you take the quizzes in order. Please make sure you
answer all questions and not leave any blanks.

Results
Score for this question group: 100%

1. At the population level, it is important to determine if the study can achieve the stated
outcomes and has the potential to answer the questions be…
True
Your correct answer
False
2. At the individual participant level, the study should be reasonable and ethical, and
safeguards against unnecessary or unacceptable risk or undue b…
True
Your correct answer
False

3. A participant in a study is informed that there is a broad range of options early in the trial
and that the options will change as the study progre…
Use of unequal randomization
Washout period for participants who need therapy
Adaptive trial designs
Your correct answer
Continuing treatment with a failed therapy

4. A single arm, open-label efficacy study of a novel drug with patient-reported outcomes of

mental health issues:
Cannot easily be replicated and is potentially biased
Your correct answer
Is a scientifically valid, ethical study

5. Which points should be considered in the choice of study design? (Check all that apply.)
Will the individual study participant improve his/her health through this study?
Is the chosen study design adequate to answer the question defined by
objectives and hypotheses?
Your correct answer
Are all the assessments, and their total number, necessary and not overly
burdensome?
Your correct answer
Does the design in any way compromise the individual or expose the
participant to harm?
Your correct answer

6. It is critically important in a first-in-human (FIH) study to justify the choice of dose given
for the first time and the safety of any increase in…
True
Your correct answer
 False

7. Using unequal randomization by exposing two times or three times as many participants
to the experimental drug or therapy than to the placebo is no…
True
False
Your correct answer

Click here to return to the course home screen 

©Copyright 2009 - 2021, Global Health Training Centre

LINKS
Contact Us
Terms & Conditions
Accessibility
Privacy Policy